Correlation Between Kiromic Biopharma and Sigilon Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kiromic Biopharma and Sigilon Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiromic Biopharma and Sigilon Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiromic Biopharma and Sigilon Therapeutics, you can compare the effects of market volatilities on Kiromic Biopharma and Sigilon Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiromic Biopharma with a short position of Sigilon Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiromic Biopharma and Sigilon Therapeutics.
Diversification Opportunities for Kiromic Biopharma and Sigilon Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Kiromic and Sigilon is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Kiromic Biopharma and Sigilon Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sigilon Therapeutics and Kiromic Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiromic Biopharma are associated (or correlated) with Sigilon Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sigilon Therapeutics has no effect on the direction of Kiromic Biopharma i.e., Kiromic Biopharma and Sigilon Therapeutics go up and down completely randomly.
Pair Corralation between Kiromic Biopharma and Sigilon Therapeutics
Given the investment horizon of 90 days Kiromic Biopharma is expected to under-perform the Sigilon Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Kiromic Biopharma is 4.14 times less risky than Sigilon Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Sigilon Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 845.00 in Sigilon Therapeutics on November 5, 2024 and sell it today you would earn a total of 1,266 from holding Sigilon Therapeutics or generate 149.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kiromic Biopharma vs. Sigilon Therapeutics
Performance |
| Timeline |
| Kiromic Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Sigilon Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Kiromic Biopharma and Sigilon Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiromic Biopharma and Sigilon Therapeutics
The main advantage of trading using opposite Kiromic Biopharma and Sigilon Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiromic Biopharma position performs unexpectedly, Sigilon Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sigilon Therapeutics will offset losses from the drop in Sigilon Therapeutics' long position.| Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
| Sigilon Therapeutics vs. Reviva Pharmaceuticals Holdings | Sigilon Therapeutics vs. ZyVersa Therapeutics | Sigilon Therapeutics vs. Unicycive Therapeutics | Sigilon Therapeutics vs. Apollomics Class A |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |